Canada vs Poland: Cause of death, by non-communicable diseases, ages 5-14, male
Canada
61.0%
in 2021
Poland
60.3%
in 2021
Canada rank
24th
Poland rank
25th
Cause of death, by non-communicable diseases, ages 5-14, male over time
- Canada
- Poland
How they compare
Canada currently reports 61.0% against 60.3% in Poland, a difference of 0.7%.
The two have swapped places 5 times across 6 shared years of data; in 2000 it was Poland ahead.
Canada ranks 24th and Poland ranks 25th of 185 countries.
Across the 3 decades both report, Canada averaged higher in 1 and Poland in 2.
Head to head by decade
| Decade | Canada | Poland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 43.5% | 45.9% | 2.4% | Poland |
| 2010s | 58.1% | 55.4% | 2.7% | Canada |
| 2020s | 57.7% | 60.1% | 2.4% | Poland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, male, Canada or Poland?
- Canada, at 61.0% against 60.3% in Poland as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, male between Canada and Poland?
- 0.7%, with Canada ahead.
- How many years of comparable data are there for Canada and Poland?
- 6 years are reported by both, from 2000 to 2021.
- How do Canada and Poland rank globally for cause of death, by non-communicable diseases, ages 5-14, male?
- Canada ranks 24th and Poland ranks 25th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, male (% of total male deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 5-14 due to non-communicable diseases divided by number of all male deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.